6
4ꢀꢀꢀꢀꢁꢀA. Moulisová and I. Linhart: Cysteine adducts by ring-opening reactions of phenyloxirane
1
Reaction of styrene oxide (1) with protected cysteines in
the presence of Lewis acid
yield 139 mg (38%); R ꢁ=ꢁ0.25 (chloroform/ethyl acetate, 10/1); H NMR
f
(
CDCl ): δ 2.85 (m, 2H), 3.69 (s, 3H), 3.82 (m, 2H), 3.99 (m, 1H), 4.60 (m,
3
1
3
1
H), 5.13 (s, 2H), 5.73 (d, 1H, J ꢁ=ꢁ 8.2 Hz), 7.32 (m, 10H); C NMR (CDCl3)
δ 34.0, 52.7, 53.6, 53.8, 65.9, 67.2, 127.9, 128.0, 128.1, 128.3, 128.6, 128.8,
To a stirred solution of protected cysteine, 2a [19] or 2b [20]
+
1
36.1, 139.1, 156.0, 171.0; HRMS: Found m/z 412.1185 [M+Na] , calcd
(
0.94 mmol) and 1 (0.12 g, 0.95 mmol) in dry dichloromethane B(C F )
+
20
6
5
3
m/z 412.1189; ESI-MS: m/z 390 [M+H] ; [ α]D -243.5° (cꢁ=ꢁ0.6, CHCl ).
3
(
25 mg, 5 mol%) was added, and stirring was continued for 3 days
at room temperature. The mixture was concentrated, and the crude
residue was purified by column chromatography using cyclohexane/
acetone 5:1 as an eluent.
Reaction of styrene oxide (1) with protected cysteines
in the presence of TBAF
N-(tert-Butoxycarbonyl)-S-(2-hydroxy-1-phenylethyl)-ꢀ-cysteine
methyl ester (3a)ꢃColorless oil; 1:1 diastereomeric mixture; yield A solution of protected cysteine 2a or 2b (0.68 mmol) and 1 (0.082 g,
1
6
7 mg (21%); R ꢁ=ꢁ0.22 (chloroform/ethyl acetate, 10/1); H NMR 0.68 mmol) in dry CH CN was treated with 1 ꢂ TBAF solution in
f
3
(
CDCl ): δ 1.43 and 1.45 (s, 9H), 2.24 (br s, 1H), 2.85 (m, 2H), 3.69 and THF (0.068 mL, 10 mol%). The solution was stirred until the reac-
3
3
.73 (s, 3H), 3.85 (m, 2H), 3.98 (m, 1H), 4.50 (m, 1H), 5.24 and 5.36 (br tion was completed as judged by thin layer chromatographic (TLC)
13
s, 1H), 7.32 (m, 5H); C NMR (CDCl ): δ 28.5, 33.9 and 34.5, 52.8, 53.6, analysis (approximately 5 h). The solvent was removed in vacuo, and
3
5
3.7, 65.9 and 66.1, 80.5, 128.1, 128.3, 129.0, 139.3 and 139.5, 155.3 and the product was then isolated by column chromatography using
+
1
55.6, 171.6; HRMS: Found m/z 378.1352 [M+Na] , calcd m/z 378.1346; cyclohexane/acetone, 5:1, as an eluent.
+
ESI-MS: m/z 356 [M+H] .
N-(tert-Butoxycarbonyl)-S-(2-hydroxy-2-phenylethyl)-ꢀ-cysteine
(
1S)-N-(tert-Butoxycarbonyl)-S-(2-hydroxy-1-phenylethyl)-ꢀ- methyl ester (4a)ꢃColorless oil; 1:1 diastereomeric mixture, yield
1
cysteine methyl ester (S,R-3a)ꢃColorless oil; one diastereomer; 125 mg, (52%), R ꢁ=ꢁ0.32 (chloroform/ethyl acetate, 10/1); H NMR
f
1
yield 65 mg (20%); R ꢁ=ꢁ0.22 (chloroform/ethyl acetate, 10/1); H NMR (CDCl ): δ 1.44 (s, 9H), 2.76 (m, 1H), 2.97 (m, 3H), 3.75 and 3.76 (s, 3H),
f
3
(
CDCl ): δ 1.43 (s, 9H), 2.88 (m, 2H), 3.74 (s, 3H), 3.86 (m, 2H), 3.97 (m, 4.57 (m, 1H), 4.76 (m, 1H), 5.43 and 5.55 (d, 1H, J ꢁ=ꢁ 7.6 and 7.6 Hz), 7.31
3
13
(m, 5H); 13C NMR (CDCl ): δ 28.3, 35.2 and 35.3, 52.6, 53.6, 53.7, 72.3
1
H), 4.50 (m, 1H), 5.23 (d, 1H, J ꢁ=ꢁ 7.4 Hz), 7.32 (m, 5H); C NMR (CDCl ):
3
3
δ 28.3, 33.7, 52.6, 53.4, 53.5, 65.6, 80.3, 127.9, 128.0, 128.8, 139.0, 155.1, and 72.6, 80.3, 125.7, 127.9, 128.5, 142.4, 155.3, 171.4; HRMS: Found m/z
+
+
+
378.1352 [M+Na] , calcd m/z 378.1346; ESI-MS: m/z 356 [M+H] .
1
71.3; HRMS: Found m/z 378.1349 [M+Na] , calcd m/z 378.1346; ESI-
+
20
MS: m/z 356 [M+H] ; [ α]D +100.5° (cꢁ=ꢁ1, CHCl ).
3
N-(Benzyloxycarbonyl)-S-(2-hydroxy-2-phenylethyl)-ꢀ-cysteine
methyl ester (4b)ꢃColorless oil; 1:1 diastereomeric mixture; yield
(
1R)-N-(tert-Butoxycarbonyl)-S-(2-hydroxy-1-phenylethyl)-ꢀ-
1
1
28 mg; (48%), R ꢁ=ꢁ0.30 (chloroform/ethyl acetate, 10/1); H NMR
cysteine methyl ester (R,R-3a)ꢃColorless oil; one diastereomer;
f
1
(CDCl ) δ 2.90 (m, 4H), 3.75 and 3.76 (s, 3H), 4.63 (m, 1H), 4.75 (m, 1H),
yield 57 mg (17%); R ꢁ=ꢁ0.22 (chloroform/ethyl acetate, 10/1); H NMR
3
f
1
3
5
(
.12 (s, 2H), 5.79 and 5.93 (br s, 1H, J ꢁ=ꢁ 7.3 Hz), 7.32 (m, 10H); C NMR
(
CDCl ): δ 1.46 (s, 9H), 2.51 (br s, 1H), 2.84 (m, 2H), 3.69 (s, 3H), 3.84
3
CDCl ) δ 35.1, 42.3 and 42.5, 52.8, 53.9 and 54.1, 67.2, 72.5 and 72.7,
(
m, 2H), 4.01 (m, 1H), 4.54 (m, 1H), 5.36 (d, 1H, J ꢁ=ꢁ 7.4 Hz), 7.32 (m, 5H);
3
13
125.7, 127.9, 128.1, 128.3, 128.6, 136.1, 142.4, 155.9, 171.1; HRMS: Found
C NMR (CDCl ): δ 28.3, 34.3, 52.6, 53.2, 53.5, 65.9, 80.3, 127.8, 128.0,
3
+
+
+
m/z 412.1198 [M+Na] , calcd m/z 412.1189; ESI-MS: m/z 390 [M+H] .
1
28.8, 139.2, 155.4, 171.3; HRMS: Found m/z 378.1349 [M+Na] , calcd
+
20
m/z 378.1346; ESI-MS: m/z 356 [M+H] ; [ α]D -103.5° (cꢁ=ꢁ1, CHCl ).
3
N-(Benzyloxycarbonyl)-S-(2-hydroxy-1-phenylethyl)-ꢀ-cysteine Deprotection of Z-protected cysteine methyl ester
methyl ester (3b)ꢃColorless oil; 1:1 diastereomeric mixture; yield
adducts 3b and 4b
1
1
45 mg (40%); R ꢁ=ꢁ0.25 (chloroform/ethyl acetate, 10/1); H NMR
f
(
CDCl ): δ 2.89 (m, 2H), 3.69 and 3.74 (s, 3H), 3.84 (m, 2H), 3.96 (m,
3
A solution of protected cysteine 3b or 4b (30 mg, 0.08 mmol) in
dichloromethane was treated at 0°C with three equivalents of
TMSI, and the mixture was stirred overnight. Then, the mixture was
quenched with water, concentrated, extracted with ethyl acetate,
1
H), 4.59 (m, 1H), 5.09 and 5.13 (s, 2H), 5.55 and 5.70 (d, 1H, J ꢁ=ꢁ 7.3 and
3
8
.0 Hz), 7.32 (m, 10H); 1 C NMR (CDCl ): δ 33.6 and 34.1, 52.8, 53.5 and
3
5
1
3.6, 53.8, 65.7 and 65.9, 67.1 and 67.2, 127.9, 128.0, 128.1, 128.2, 128.5,
28.8, 136.0, 138.9 and 139.1, 155.7 and 155.9, 171.0; HRMS: Found m/z
and dried over MgSO . The solvent was evaporated, and the resulting
+
+
4
4
12.1194 [M+Na] , calcd m/z 412.1189; ESI-MS: m/z 390 [M+H] .
N-deprotected methyl ester was hydrolyzed with aqueous NaOH (1 ꢂ,
0
.1 mL) diluted with 1 mL of methanol. The solvent was evaporated,
(
1S)-N-(Benzyloxycarbonyl)-S-(2-hydroxy-1-phenylethyl)-ꢀ-
the residue was diluted with water, and the pH level of the solution
was adjusted to 5–6 before analysis by LC/MS.
cysteine methyl ester (S,R-3b)ꢃColorless oil; one diastereomer;
1
yield 128 mg (35%); R ꢁ=ꢁ0.25 (chloroform/ethyl acetate, 10/1); H NMR
f
(
CDCl ): δ 2.91 (m, 2H), 3.73 (s, 3H), 3.83 (m, 2H), 3.94 (m, 1H), 4.55 (m,
3
13
1
H), 5.09 (s, 2H), 5.60 (d, 1H, J ꢁ=ꢁ 7.8 Hz), 7.32 (m, 10H); C NMR (CDCl ):
3
Deprotection of Boc-protected cysteine methyl ester
adducts 3a and 4a
δ 33.5, 52.7, 53.4, 53.8, 65.8, 67.1, 127.9, 128.0, 128.1, 128.2, 128.5, 128.8,
+
1
36.1, 139.0, 155.7, 171.0; HRMS: Found m/z 412.1187 [M+Na] , calcd
+
20
m/z 412.1189; ESI-MS: m/z 390 [M+H] ; [ α]D +137.1° (cꢁ=ꢁ0.6, CHCl ).
3
Protected compound 3a or 4a (30 mg, 0.09 mmol) was dissolved in a
(
1R)-N-(Benzyloxycarbonyl)-S-(2-hydroxy-1-phenylethyl)-ꢀ- 1:1 mixture of TFA and dichloromethane. The solution was stirred at
cysteine methyl ester (R,R-3b)ꢃColorless oil; one diastereomer; room temperature for 4 h then concentrated on a rotary evaporator.
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 5/29/15 9:54 PM